Gene · 1616
Papers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TSG101 depletion dysregulates mitochondria and PML NBs, triggering MAD2-overexpressing interphase cell death (MOID) through AIFM1-PML-DAXX pathway. | Cell Death Dis | 2024 | 39551802 | PubTator, text mining | PubMed |
| Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia. | Sci Rep | 2024 | 39521940 | PubTator, text mining | PubMed |
| Mutant ATRX: pathogenesis of ATRX syndrome and cancer. | Front Mol Biosci | 2024 | 39479502 | PubTator, text mining | PubMed |
| Subtyping of pancreatic neuroendocrine tumors by transcription factors, hormones, histology, and patient outcome. | Pathologie (Heidelb) | 2024 | 39377913 | PubTator, text mining | PubMed |
| The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation. | J Pathol | 2024 | 39360347 | PubTator, text mining | PubMed |
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres). | Endocr Pathol | 2024 | 39331358 | PubTator, text mining | PubMed |
| Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors. | Cancers (Basel) | 2024 | 39272851 | PubTator, text mining | PubMed |
| Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm. | Diagn Pathol | 2024 | 39267076 | PubTator, text mining | PubMed |
| The Impact of DAXX, HJURP and CENPA Expression in Uveal Melanoma Carcinogenesis and Associations with Clinicopathological Parameters. | Biomedicines | 2024 | 39200236 | PubTator, text mining | PubMed |
| Hippophae Rhamnoides-derived Phytomedicine Nano-System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple-Negative Breast Cancer. | Adv Healthc Mater | 2024 | 39132863 | PubTator, text mining | PubMed |
| MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. | Endocr Relat Cancer | 2024 | 39093924 | PubTator, text mining | PubMed |
| Investigating the structural and functional consequences of germline single nucleotide polymorphisms located in the genes of the alternative lengthening of telomere (ALT) pathway. | Heliyon | 2024 | 39021990 | PubTator, text mining | PubMed |
| Case report: Precision guided reactive cancer management: molecular complete response in heavily pretreated metastatic CRC by dual immunotherapy and sorafenib. | Front Oncol | 2024 | 39011472 | PubTator, text mining | PubMed |
| Protein Condensate Atlas from predictive models of heteromolecular condensate composition. | Nat Commun | 2024 | 38987300 | PubTator, text mining | PubMed |
| Immunotherapy-relevance of a candidate prognostic score for Acute Myeloid Leukemia. | Heliyon | 2024 | 38961904 | PubTator, text mining | PubMed |
| Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer. | Eur J Endocrinol | 2024 | 38917236 | PubTator, text mining | PubMed |
| Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity. | Hum Pathol | 2024 | 38909708 | PubTator, text mining | PubMed |
| Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data. | Front Endocrinol (Lausanne) | 2024 | 38868744 | PubTator, text mining | PubMed |
| Microglial Pdcd4 deficiency mitigates neuroinflammation-associated depression via facilitating Daxx mediated PPARγ/IL-10 signaling. | J Neuroinflammation | 2024 | 38822367 | PubTator, text mining | PubMed |
| The antiviral state of the cell: lessons from SARS-CoV-2. | Curr Opin Immunol | 2024 | 38795501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1616/papers?page=8